IP Library › Granted Patent US 11,713,922
Granted Patent B2
US 11,713,922 · App. 17/985,250 · Granted Aug 1, 2023

Target residual moisture content for lyophilized drug product

Inventors: Xiaolin Tang (Old Tappan, NJ); Mary Kleppe (Milford, CT); Ravi Chari (Norwich, CT); Franco Tzul (Cortlandt Manor, NY)
Assignee: Regeneran Pharmaceuticals, Inc.
F26B5/06A61K9/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,713,922
App. No.
17/985,250
Granted
Aug 1, 2023
Kind
B2
Abstract

Lyophilization methods for preparing protein formulations for long-term storage at room temperature or improved stability at refrigeration storage are provided. Specifically, the present application provides lyophilization methods to obtain a target percentage of residual moisture of a lyophilized product, such as 3-5% residual moisture. The secondary drying of the lyophilization can be conducted under controlling rate of desorption under a temperature which is similar to the shelf temperature of the primary drying. Alternatively, the lyophilization can be conducted without a distinguished secondary drying step.

Claims (21)

1. A method for preparing a lyophilized cake, comprising:

preparing a formulation, wherein the formulation comprises at least one solvent molecule and a peptide or protein;

subjecting the formulation to lyophilization to obtain the lyophilized cake, including:

placing the formulation in a chamber of a freeze-dryer,

freezing the formulation,

conducting drying on the formulation to remove the at least one frozen solvent molecule by sublimation, wherein the drying is conducted at a shelf temperature of the freeze-dryer that is equal to or below about 0° C.; and

controlling the rate of desorption of the at least one solvent molecule by continuing the drying on the formulation to remove the at least one solvent molecule to obtain a target weight percentage of the at least one solvent molecule in the lyophilized cake.

2. The method of claim 1 , wherein the target weight percentage of the at least one solvent molecule in the lyophilized cake is controlled by the shelf temperature of the freeze-dryer with a controlled drying rate.

3. The method of claim 1 , wherein the target weight percentage of the at least one solvent molecule in the lyophilized cake is controlled by a duration of time.

4. The method of claim 1 , wherein the target weight percentage of the at least one solvent molecule in the lyophilized cake is about 3-5%, about 4% or about 4.5%.

5. The method of claim 1 , wherein the peptide or protein is an antibody, an antibody fragment, a Fab region of an antibody, an antibody-drug conjugate, a fusion protein, a protein pharmaceutical product or a drug.

6. The method of claim 1 , wherein the lyophilized cake is stable under the storage condition at room temperature or has improved stability for refrigeration storage.

7. The method of claim 1 , wherein the at least one solvent molecule is a water molecule.

8. The method of claim 1 , further comprising determining an ending of the drying based on a change of a pressure in the chamber of the freeze-dryer.

9. The method of claim 1 , wherein the formulation further comprises a buffer, an excipient, a stabilizer, a cryo-protectant, a bulking agent, a plasticizer, or a combination thereof.

10. The method of claim 9 , wherein the buffer comprises acetate and/or histidine hydrochloride.

11. The method of claim 9 , wherein the buffer has a pH value of about 5.3 to about 6.

12. The method of claim 9 , wherein the excipient is polysorbate 80.

13. The method of claim 9 , wherein the stabilizer is sucrose, wherein the ratio of sucrose to the peptide or protein is about 1:1, about 3:1, about 10:1, or about 1:1 to 10:1.

14. The method of claim 9 , wherein the stabilizer is polyol, sucrose, mannitol, trehalose, sorbitol, an amino acid, or a combination thereof.

15. The method of claim 9 , wherein the cryo-protectant is a surfactant, sugar, salt, an amino acid, or a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2023
From: TANG, XIAOLIN; KLEPPE, MARY; CHARI, RAVI; TZUL, FRANCO
To: REGENERON PHARMACEUTICALS, INC
Reel/Frame 063013/0500 →
Continuity (3)
Continuation 17167527 · Feb 4, 2021
Provisional Application 62969961 · Feb 4, 2020
Related Publication 20230077563A1 · Mar 16, 2023
Cited By (1)
US 12,449,198